Moreover, NSD2 directly methylates active regulator of SIRT1 (AROS) at K27 to facilitate its interaction with SIRT1, resulting in SIRT1 activation and enhanced fatty acid oxidation in colorectal cancer [45]. Here, NSD2 is linked to colorectal cancer.